Navigation Links
Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis
Date:2/26/2009

INDIANAPOLIS, Feb. 26 /PRNewswire-USNewswire/ -- America's pharmaceutical research and biotechnology companies are testing a record number of potential medicines to treat two of the country's top killers. According to the latest report by the Pharmaceutical Research and Manufacturers of America (PhRMA) on medicines in the research pipeline, over 300 new medicines are in development to treat heart disease and stroke.

"This report reflects the never-ending commitment of our scientists and companies to improve healthcare by fighting debilitating chronic diseases, which often have devastating impacts on patients, their families and the American economy," said PhRMA Senior Vice President Ken Johnson at today's press conference. "This report also illustrates why the U.S. leads the world in discovering and developing new medicines."

More research and development of new medicines takes place in the U.S. than in any other country. Indiana has a fair share of that, with more than 6 percent of the nation's pharmaceuticals workforce employed in the Hoosier state. At least 10 pharmaceutical companies are headquartered in Indiana, and at least 13 additional companies maintain a division, branch or manufacturing plant in Indiana. National Institutes of Health funding for Indiana's biosciences has grown nearly twice the national rate over the past six years. The biopharmaceutical research industry contributes significantly to the state's economy.

The 312 heart and stroke medicines now being developed, more than double the number (146) under development in 2005. Innovative potential heart and stroke medicines - five being developed here in Indiana - hold particular relevance to Hoosiers because cardiovascular disease and stroke are the leading causes of death in the state. Indiana also ranks high for many factors that increase the risk of developing cardiovascular disease, including higher-than-national rates for smoking, hi
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
2. ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimers Disease
3. New Report by BioTrends Research Group to Highlight the Launch of ULORIC(R) (febuxostat)
4. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
5. Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer
6. Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
7. Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist
8. Blue Light Destroys Antibiotic-Resistant Staph Infection - Results Reported in Photomedicine and Laser Surgery Journal
9. MannKind Reports Successful Completion of Device Bioequivalence Trial
10. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
11. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)...  Rigrodsky & Long, P.A.: , Do you, ... LCI )? , Did you purchase your shares before ... 2014, inclusive? , Did you lose money in your ... to discuss your rights? Rigrodsky & ... Timothy J. MacFall , announces that a complaint has been filed ...
(Date:8/28/2014)... NEW YORK , Aug. 28, 2014 /PRNewswire/ ... report is available in its catalogue: ... http://www.reportlinker.com/p02343464/North-America-Laparoscopes-Market-Outlook-to-2020.html North ... GlobalData,s new report, "North America Laparoscopes Market ... the North America Laparoscopes market. The report provides ...
(Date:8/28/2014)... N.J. , Aug. 28, 2014 /PRNewswire-iReach/ -- ... medical device space, is excited to announce they ... the VIEW Plating System and REDUCE Fracture Plating ... anatomic plates used to support multiple indications within ... packaged Lapidus, First Metatarsophalangeal (MTP), Calcaneal-Cuboid (CC), Talonavicular ...
Breaking Medicine Technology:Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3North America Laparoscopes Market Outlook to 2020 2North America Laparoscopes Market Outlook to 2020 3North America Laparoscopes Market Outlook to 2020 4North America Laparoscopes Market Outlook to 2020 5North America Laparoscopes Market Outlook to 2020 6North America Laparoscopes Market Outlook to 2020 7North America Laparoscopes Market Outlook to 2020 8North America Laparoscopes Market Outlook to 2020 9North America Laparoscopes Market Outlook to 2020 10North America Laparoscopes Market Outlook to 2020 11EDGE Orthopaedics Receives Second FDA Clearance 2
... 2011 Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ... candidate, has been granted orphan drug designation from the ... of pediatric Clostridium difficile infection (CDI).  This ... covers all formulations of fidaxomicin used to treat ...
... 2011 ULURU Inc. (NYSE Amex: ULU), ... a portfolio of wound management and oral care products, today ... 5,000,000 shares of its common stock at a price per ... an institutional investor, resulting in gross proceeds of approximately $500,000. ...
Cached Medicine Technology:Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection 2Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection 3Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection 4ULURU Inc. to Raise $500,000 in Registered Direct Offering 2
(Date:8/28/2014)... Wilmington, DE (PRWEB) August 28, 2014 Blood's ... murder, gunplay, sex, money and family ties in the heart ... like no other – a story about how disrespect caused ... and limbs on many streets. , The Yayo Boyz and ... leave news reporters speechless and local onlookers in a silent ...
(Date:8/28/2014)... Ariz. (PRWEB) August 28, 2014 Arizona ... Force Impact Technologies , has been named one of ... the Year competition. , This is the fourth consecutive ... in the competition. Jared Schoepf, co-founder of SafeSIPP, and ... 2013 and 2012, respectively. In 2011, ASU dominated the ...
(Date:8/28/2014)... -- Arguments between parents may damage their relationships with ... more than 200 families were asked to make daily ... each day, mothers and fathers rated the quality of ... On days when parents reported conflict and tension in ... strained, according to the study recently published in the ...
(Date:8/28/2014)... ABC television stars will join forces ... of Strength Telethon airing Sunday, Aug. 31, 9/8c on ... funds and awareness to help save and improve the ... , Viewers tuning into the 2014 telethon to benefit ... introductions from some of the network’s leading stars, including ...
(Date:8/28/2014)... 2014 The Governor of Yucatán, Rolando ... at a press conference; this event is organized by ... of Economy through the National Microenterprise Financing Program ( ... to the 5th at the Convention Center Yucatan Siglo ... a great responsibility for Yucatan to host the 17th ...
Breaking Medicine News(10 mins):Health News:Raymond E. Blake Releases Blood's Thicker Than Water, Based on a True Story 2Health News:Arizona State University Grad Student in the Running for College Entrepreneur of the Year 2Health News:Arizona State University Grad Student in the Running for College Entrepreneur of the Year 3Health News:Parents' Fights May Strain Bonds With Their Kids 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 3Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 4Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 2Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 3
... that ,less affirming, isolating behaviors jump from friend to friend ... suggests that lonely people attract fellow "lonelies" and influence others ... to person to person -- up to three degrees of ... in the December issue of the Journal of Personality ...
... 2009) Wistar Institute researchers and collaborators from the University ... markers in the blood which indicate early-stage lung tumors in ... published online December 1 in Cancer Research , a ... to a simple blood test to detect lung cancer in ...
... ... business requiring dictation and transcription are breathing a sigh of relief this week with the ... anyone required to dictate and transcribe voice recordings to do so quickly and seamlessly using ... ...
... TRIANGLE PARK, N.C., Dec. 1 Max Neeman Pharmacy services were ... top most pharmaceutical companies globally. The facility which was originally set ... in size. Pharmacy services, as part of the suite of services ... a valuable offering. , The pharmacy inventory management process is considerably ...
... , , LEHIGH VALLEY, Pa., Dec. 1 ... it has completed the previously announced sale of the assets ... Versathane® tradenames to COIM USA Inc., a fully owned subsidiary ... in the sale was Air Products, manufacturing facility in Paulsboro, ...
... , WASHINGTON, Dec. 1 Individuals ... with traditional coverage to exhibit a number of cost-conscious behaviors, ... more inclined to think that financial incentives matter in holding ... nonpartisan Employee Benefit Research Institute (EBRI). , At the ...
Cached Medicine News:Health News:Loneliness May Be Catching 2Health News:Loneliness May Be Catching 3Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4
PDA application containing all 7,000+ Physicians' Current Procedural Terminology codes developed by the American Medical Association....
PDA application contains 15,000+ ICD-9-CM Diagnosis codes....
Contains the most common procedures from all orthopedic sub-specialties organized by body area....
Athouritative, on the spot answers for acute care and consultations....
Medicine Products: